The influence of old age on cardioprotective efficiency of pharmacological postconditioning using lactic acid in ischemia-reperfusion of the myocardium in experiment

Not only the prevalence, but also the death rate from the coronary heart disease, including myocardial infarction, is higher in older people than among young people. A demographic shift towards an aging population will lead to a further increase in the prevalence of cardiovascular diseases among the elderly population. Therefore, one of the urgent aims of modern experimental and clinical medicine is to develop methods aimed at limiting reversible and irreversible damage to the myocardium, including in elderly patients. There are a lot of the data supporting the cardioprotective efficiency of such phenomena as ischemic and pharmacological pre- and postconditioning that reduce ischemic and reperfusion damage in young hearts. However, the information on the effectiveness of these phenomena in experiments on old animals is very scarce, contradictory, and not fully understood. The aim of the study was to experimentally evaluate the influence of old age on the reproducibility of the cardioprotective efficiency of pharmacological postconditioning using lactic acid in ischemia-reperfusion of the myocardium. In the course of the study, it was found that neutral lactate, after being administered into the blood flow of animals at a dose of 10 mg/kg 25 minutes after the onset of reperfusion, leads to a decrease in the infarct size of the left ventricle of the myocardium in old rats. Pharmacological postconditioning using lactate is not effective in reducing the duration of cardiac arrhythmias in ischemia-reperfusion of the myocardium in old rats; however, there is a tendency to reduce the incidence of reperfusion arrhythmias and the total duration of cardiac arrhythmias. The obtained data suggest that the presence of such a risk factor for cardiovascular diseases as old age is not a criterion to exclude the use of pharmacological postconditioning with lactate as a way to reduce ischemia and reperfusion injury of myocardium.

1. The top 10 causes of death. World Health Organization. Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (accessed 10.02.2021).

2. Bautin A. E., Karpova L. I., Marichev A. O., Tashkhanov D. M., Naumenko V. S., Galagudza M. M. Cardioprotective effects of ischemic conditioning: current concepts of mechanisms, experimental evidence, clinical implementation. Translyatsionnaya meditsina = Translational Medicine, 2016, vol. 3, no. 1, pp. 50–62 (in Russian). https://doi.org/10.18705/2311-4495-2016-3-1-50-62

3. Shlyakhto E. V., Nifontov E. M., Galagudza M. M. Limitation of ischemic and reperfusion injury of the myocardium using pre- and postconditioning: molecular mechanisms and targets for pharmacotherapy. Kreativnaya kardiologiya = Creative cardiology, 2007, no. 1–2, pp. 75–101 (in Russian).

4. Heusch G. Molecular basis of cardioprotection: signal transduction in ischemic pre, post, and remote conditioning. Circulation Research, 2015, vol. 116, pp. 674–699. https://doi.org/10.1161/CIRCRESAHA.116.305348

5. Zhao Z.-Q., Corvera J. S., Halcos M. E., Kerendi F., Wang N. P., Guyton R. A., Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. American Journal of Physiology ‒ Heart and Circulatory Physiology, 2003, vol. 285, pp. H579–H588. https://doi.org/10.1152/ajpheart.01064.2002

6. Galagudza M. M., Blokhin I. O., Shmonin A. A., Mischenko K. A. Reduction of myocardial ischaemia-reperfusion injury with pre- and postconditioning: molecular mechanisms and therapeutic targets. Cardiovascular & Hematological Disorders-Drug Targets, 2008, vol. 8, no. 1, pp. 47–65. https://doi.org/10.2174/187152908783884966

7. Basalay М., Barsukevich V., Mastitskaya S., Mrochek A., Pernow J., Sjoquist P. O., Ackland G. L., Gourine A. V., Gourine A. Remote ischaemic pre- and delayed postconditioning – similar degree of cardioprotection but distinct mechanisms. Experimental Physiology, 2012, vol. 97, no. 8, pp. 908–917 (in Russian). https://doi.org/10.1113/expphysiol.2012.064923

8. Donato M., Evelson P., Gelpi R. J. Protecting the heart from ischemia/reperfusion injury: an update on remote ischemic preconditioning and postconditioning. Current Opinion in Cardiology, 2017, vol. 32, no. 6, pp. 784–790. https://doi.org/10.1097/HCO.0000000000000447

9. Vismont F. I., Chepelev S. N., Jushkevich P. F. Peripheral M-choline-reactive systems in the infarct-limited effect implementation of remote ischemic postconditioning during ischemia-reperfusion of myocardium in experiment. Vestsi Natsyyanal’nai akademii navuk Belarusi. Seriya meditsinskikh navuk = Proceedings of the National Academy of Sciences of Belarus. Medical series, 2019, vol. 16, no. 4, pp. 424–433 (in Russian). https://doi.org/10.29235/1814-6023-2019-16-4-424-433

10. Chepelev S. N., Vismont F. I. Significance of nitrogen monoxide in the implementation of the infarctlimiting effect of remote ischemic postconditioning in myocardial ischemia-reperfusion in young and old rats. Vestsi Natsyyanal’nai akademii navuk Belarusi. Seriya meditsinskikh navuk = Proceedings of the National Academy of Sciences of Belarus, Medical series, 2020, vol. 17, no. 3, pp. 353–364 (in Russian). https://doi.org/10.29235/1814-6023-2020-17-3-353-363

11. Groussard C., Morel I., Chevanne M., Monnier M., Cillard J., Delamarche A. Free radical scavenging and antioxidant effects of lactate ion: an in vitro study. Journal of Applied Physiology (1985), 2000, vol. 89, no. 1, pp. 169–175. https://doi.org/10.1152/jappl.2000.89.1.169

12. Ichai C., Leverve X., Orban J. C. Lactate and acute heart failure syndrome. Mebazaa A., Gheorghiade M., Zannad F. M., Parrillo J. E. (eds.). Acute Heart Failure. London, 2008, pp. 768–780. https://doi.org/10.1007/978-1-84628-782-4_70

13. Chepelev S. N., Vismont F. I., Goubkin S. V. On the significance of hyperlactatemia in the implementation of the infarct-limiting effect of remote ischemic postconditioning in myocardial ischemia-reperfusion in the experiment. Doklady Natsional’noi akademii nauk Belarusi = Doklady of the National Academy of Sciences of Belarus, 2020, vol. 64, no. 3, pp. 332–340 (in Russian). https://doi.org/10.29235/1561-8323-2020-64-3-332-340

14. Chepelev S. N., Vismont F. I. Infarct-limiting effciency of pharmacological postconditioning using lactic acid in the experiment of myocardial ischemia-reperfusion. Meditsinskiy zhurnal = Medical Journal, 2021, no. 1 (75), pp. 104–109 (in Russian).

15. Ruiz-Meana M., Boengler K., Garcia-Dorado D., Hausenloy D. J., kaambre T., Kararigas G., Perrino C., Schulz R., Ytrehus k. Ageing, sex, and cardioprotection. British Journal of Pharmacology, 2020, vol. 177, no. 23, pp. 5270–5286. https://doi.org/10.1111/bph.14951